Philips shares fall 8% after U.S. drug regulator deals fresh blow to sleep device recall

Shares of Dutch health tech company Philips fell on Friday after the U.S. drug regulator deemed its handling of a major product recall inadequate.

from Health and Science https://ift.tt/29pnQby
https://ift.tt/R6GC3s1
https://ift.tt/g5Esoti